Trials Sponsors Conditions Drugs Pricing

Conditions

Post-traumatic Stress Disorder Stress Disorder, Post-Traumatic

Keywords

PTSD

Outcome Measures

Primary Outcomes (2)

PTSD Symptoms assessed by PCL-M score
PTSD symptoms will be measured by PCL-M score
8-12 weeks
Depression Symptoms assessed by Beck Depression Inventory-II
Beck Depression Inventory-II will be used to measure depression
8-12 weeks

Secondary Outcomes (2)

Treatment Satisfaction assessed by Likert scale
8-12 weeks
Treatment completion assessed by dropout rate
8-12 weeks

Study Arms (3)

Control

ACTIVE COMPARATOR

Subjects will receive 8 sessions of Cognitive Processing Therapy.

Behavioral: Cognitive Processing therapy

Experimental

EXPERIMENTAL

Subjects will receive 8 sessions of CPT + Art Therapy 8 sessions of individual therapy.

Behavioral: Art + CPT

Experimental 2

EXPERIMENTAL

Subject to receive 8 sessions of individual therapy for Art + CPT Cognitive Processing Therapy intervention pre-specified to be administered separately.

Interventions

Cognitive Processing therapyBehavioral

8 sessions of standard CPT from CPT manual developed by Dr. S Resick, Monson \& Chard (11/2010)

Also known as: CPT

Control

Art + CPTBehavioral

8 sessions of individual therapy of mixes techniques Art + CPT 8 sessions of standard CPT (same 8 as in control group) from manual developed by Dr.s Resick, Monson \& Chard (11/2010)

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

PCL-M initial score \>= 50;
Both genders,

Sponsors & Collaborators

Hampton VA Medical Center
US federal agencylead

Study Sites (1)

Hampton VA Medical Center

Hampton, Virginia, 23667, United States

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Interventions

2-cyclohexylidenhydrazo-4-phenyl-thiazoleReproductive Techniques, AssistedArt Therapy

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Reproductive TechniquesTherapeuticsInvestigative TechniquesSensory Art TherapiesComplementary Therapies

Study Officials

Barbara Cross, Ph.D., FNP
IRB Chair
STUDY CHAIR

Enrollment

31 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: RANDOMIZED
Masking: NONE
Purpose: TREATMENT
Intervention Model: PARALLEL
Sponsor Type: FED
Responsible Party: SPONSOR

Study Record Dates

First Submitted

November 17, 2015

First Posted

November 20, 2015

Study Start

November 2013

Actual (reported)

Study Stopped

Trial of Art Therapy During Cognitive Processing Therapy for PTSD

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (2)

Study Arms (3)

Control

Experimental

Experimental 2

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (2)

Study Arms (3)

Control

Experimental

Experimental 2

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations